Last edition
News about Manufacturing
The Global Antibiotic Research & Development Partnership (GARDP) and India-based Orchid Pharma Ltd (Orchid) have signed a sublicense agreement to manufacture cefiderocol, an antibiotic to treat certain Gram-negative infections.
Manufacturing | 13/09/2023 | By Manvi | 662
UK MHRA Renews GMP Compliance of Kopran's Two Plants
This development illustrates the company's commitment to work closely with the MHRA-UK and strive for 100 Percent cGMP Compliance at its manufacturing facilities.
Manufacturing | 04/09/2023 | By Manvi | 1128
Tetra Pharm Technologies inaugurates new R&D, manufacturing and production facility
Tetra Pharm Technologies inaugurates new R&D, manufacturing and production facility
Manufacturing | 17/08/2023 | By Sudeep Soparkar | 650
Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood
Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood
Manufacturing | 14/08/2023 | By Sudeep Soparkar | 1015
MedPlus looks to set up own pharma manufacturing units
MedPlus looks to set up own pharma manufacturing units
Manufacturing | 10/08/2023 | By Sudeep Soparkar | 4133
Genomma Lab Manufacturing Facility Granted Cofepris Operating Licence For All Its Pharma / OTC Manufacturing Lines
Manufacturing | 08/08/2023 | By Sudeep Soparkar | 1131
Bora Pharmaceuticals Unveils New Facility for Ophthalmic Manufacturing
Bora Pharmaceuticals Unveils New Facility for Ophthalmic Manufacturing
Manufacturing | 02/08/2023 | By Sudeep Soparkar | 1037
Biovian Invests Over 50M Euro in Manufacturing Facility in Finland
Biovian Invests Over €50M in Manufacturing Facility in Finland
Manufacturing | 31/07/2023 | By Sudeep Soparkar | 842
AmbioPharm Aims Global Peptide CDMO Expansion with China and US Facilities
A reliable peptide CDMO with manufacturing facilities both in China and the USA, AmbioPharm is ready to meet the needs of a global market.
Manufacturing | 28/07/2023 | By Manvi | 2449
Scottish Researchers Explore Use of PET Plastic for Manufacturing Pharmaceuticals
Using genetically modified bacteria and enzymes to break down the plastic waste, the core chemical components can then be converted into valuable pharmaceuticals.
Manufacturing | 26/07/2023 | By Manvi | 495
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy